DK0619734T3 - Nye farmaceutiske formuleringer af 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol - Google Patents

Nye farmaceutiske formuleringer af 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol

Info

Publication number
DK0619734T3
DK0619734T3 DK91915138T DK91915138T DK0619734T3 DK 0619734 T3 DK0619734 T3 DK 0619734T3 DK 91915138 T DK91915138 T DK 91915138T DK 91915138 T DK91915138 T DK 91915138T DK 0619734 T3 DK0619734 T3 DK 0619734T3
Authority
DK
Denmark
Prior art keywords
methylthiazole
hydroxyethyl
chloro
pharmaceutical formulations
new pharmaceutical
Prior art date
Application number
DK91915138T
Other languages
Danish (da)
English (en)
Inventor
Bernard Robin Boar
Alan John Cross
Alfred Richard Green
Curt-Eric Hagberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of DK0619734T3 publication Critical patent/DK0619734T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK91915138T 1990-08-15 1991-08-07 Nye farmaceutiske formuleringer af 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol DK0619734T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002659A SE9002659D0 (sv) 1990-08-15 1990-08-15 New pharmaceutical formulations
PCT/SE1991/000522 WO1992003134A1 (en) 1990-08-15 1991-08-07 New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole

Publications (1)

Publication Number Publication Date
DK0619734T3 true DK0619734T3 (da) 1998-10-05

Family

ID=20380161

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915138T DK0619734T3 (da) 1990-08-15 1991-08-07 Nye farmaceutiske formuleringer af 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol

Country Status (26)

Country Link
US (1) US5385921A (xx)
EP (1) EP0619734B1 (xx)
JP (1) JP3094077B2 (xx)
AT (1) ATE164066T1 (xx)
AU (1) AU657490B2 (xx)
BG (1) BG97446A (xx)
CA (1) CA2088775A1 (xx)
CZ (1) CZ279586B6 (xx)
DE (1) DE69129126T2 (xx)
DK (1) DK0619734T3 (xx)
ES (1) ES2114891T3 (xx)
FI (1) FI930608A0 (xx)
HU (1) HUT65821A (xx)
IE (1) IE912818A1 (xx)
IL (1) IL99169A (xx)
IS (1) IS3743A7 (xx)
LT (1) LT3978B (xx)
LV (1) LV10921B (xx)
NO (1) NO303447B1 (xx)
NZ (1) NZ239329A (xx)
PT (1) PT98688B (xx)
RO (1) RO112994B1 (xx)
RU (1) RU2093155C1 (xx)
SE (1) SE9002659D0 (xx)
SK (1) SK8793A3 (xx)
WO (1) WO1992003134A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901658D0 (sv) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
WO2002083863A2 (en) 2001-04-17 2002-10-24 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
CN103772313B (zh) * 2014-01-02 2015-10-14 郑桂富 一种4-甲基-5-(2-羟乙基)噻唑的合成方法
CN112262814A (zh) * 2020-10-26 2021-01-26 宜宾学院 油樟叶渣发酵床养鸡方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2825966A1 (de) * 1978-06-14 1980-01-03 Basf Ag Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt
GB8600783D0 (en) * 1986-01-14 1986-02-19 Merck Sharp & Dohme N-methyl-d-aspartate receptor antagonists

Also Published As

Publication number Publication date
HUT65821A (en) 1994-07-28
EP0619734B1 (en) 1998-03-18
US5385921A (en) 1995-01-31
CZ16693A3 (en) 1994-02-16
FI930608A (fi) 1993-02-11
WO1992003134A1 (en) 1992-03-05
IL99169A (en) 1995-10-31
NO930452L (no) 1993-02-09
IE912818A1 (en) 1992-02-26
IS3743A7 (is) 1992-02-16
CZ279586B6 (cs) 1995-05-17
SE9002659D0 (sv) 1990-08-15
SK8793A3 (en) 1993-07-07
LT3978B (en) 1996-06-25
PT98688A (pt) 1992-07-31
AU8409291A (en) 1992-03-17
LTIP1714A (en) 1995-09-25
NO303447B1 (no) 1998-07-13
JP3094077B2 (ja) 2000-10-03
DE69129126D1 (de) 1998-04-23
NO930452D0 (no) 1993-02-09
FI930608A0 (fi) 1993-02-11
AU657490B2 (en) 1995-03-16
NZ239329A (en) 1994-11-25
ES2114891T3 (es) 1998-06-16
LV10921B (en) 1996-08-20
DE69129126T2 (de) 1998-07-23
RO112994B1 (ro) 1998-03-30
JPH06500097A (ja) 1994-01-06
PT98688B (pt) 1999-01-29
EP0619734A1 (en) 1994-10-19
CA2088775A1 (en) 1992-02-16
ATE164066T1 (de) 1998-04-15
HU9300388D0 (en) 1993-04-28
RU2093155C1 (ru) 1997-10-20
IL99169A0 (en) 1992-07-15
LV10921A (lv) 1995-12-20
BG97446A (en) 1994-03-24

Similar Documents

Publication Publication Date Title
DK0513387T3 (da) Thiazolderivater som inhibitorer af aktivt oxygen
DE69227407D1 (de) Superlumineszierende optische Quelle
FI913248A (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
ITMI913324A1 (it) Composizione farmaceutica che comprende una particolare forma fisica di un derivato di un'ammide eterociclica
LV10269A (lv) Dialkoksipiridinilbenzimidazola atvasinajumi farmaceitiskas kompozicijas inhibesanas panemiens izmantosana
YU74292A (sh) Jedinjenja za inhibiciju hiv i srodnih virusa
DK0532595T3 (da) Farmakologisk anvendelse af visse cystinderivater
NO180445C (no) 2-(4-hydroksypiperidino)-1-alkanol-derivater som anti-iskemiske midler
DK0619734T3 (da) Nye farmaceutiske formuleringer af 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
DK0521967T3 (da) Ny anvendelse af bambuterol
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
RU93004984A (ru) Фармацевтическая композиция на основе 5(2-хлор-1-гидроксиэтил)-4-метилтиазола, применение 5-(2-хлор-1-гидроксиэтил)-4-метил-тиазола для лечения, способ лечения, соли 5-(2-хлор-1-гидроксиэтил)-4-метилтиазола
BR9706491A (pt) Compostos de elipticina processo para a sua preparação e composições farmacêuticas contendo os mesmos
SE9000288D0 (sv) New use
NO911665D0 (no) Fremgangsmaate for fremstilling av nye nojirimycinderivater
IT9022493A0 (it) Composizione farmaceutica a rilascio controllato contenente un sale farmaceuticamente accettabile di buflomedil
FI980376A (fi) N-/4-/5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli/-3-metoksibentsoyyli/-2-metyylibentseenisulfonamidin fysikaalista muotoa sisältävä farmaseuttinen koostumus
MX9203359A (es) Nuevas composiciones farmaceuticas de insulina.
ITRM910200A0 (it) Procedimento per la produzione di lenti oftalmiche a contatto.
FI903384A (fi) Derivat av taxol och foerfaranden foer deras framstaellning.
MX9202442A (es) Derivados de azol.